Laurus Labs Limited vs Medico Remedies Limited

A side-by-side comparison of Laurus Labs Limited (LAURUSLABS) and Medico Remedies Limited (MEDICO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

Laurus Labs Limited vs Medico Remedies Limited are evenly matched on the numbers (7–7). The breakdown below shows where each one wins.

  • Valuation22
  • Profitability22
  • Growth02
  • Size & financial health31
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

Even

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

125.08
P/E ratio
13.98
19.74
P/B ratio
3.96
0.10%
Dividend yield
0.00%
₹16.47
EPS
₹1.58

Profitability

Even

How efficiently each company turns capital and sales into profit. Higher is better.

16.77%
Return on equity
17.38%
17.58%
Return on capital
20.98%
26.09%
EBITDA margin
8.25%
13.07%
Net margin
6.36%

Growth

MEDICO takes 2/2

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

4.09%
Revenue CAGR (3Y)
13.81%
3.91%
Profit CAGR (3Y)
23.29%

Size & financial health

LAURUSLABS takes 3/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹1.11L Cr
Market cap
₹182 Cr
₹6,813 Cr
Revenue
₹206 Cr
₹890 Cr
Net profit
₹13 Cr
0.45
Debt / equity
0.25
Laurus Labs Limited
  • + []
  • − ["Stock is trading at 21.00 times its book value", "The company has delivered a poor sales growth of 7.2% over past five years.", "The company has delivered a poor profit growth of -2.0% over past five years."]
Medico Remedies Limited
  • + ["Company has delivered good profit growth of 34.3% CAGR over last 5 years"]
  • − ["Though the company is reporting repeated profits, it is not paying out dividend"]
Laurus Labs Limited full analysis Medico Remedies Limited full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.